Clinical Trial: A Clinical Trial to Evaluate the Efficacy and Safety of HL-1186 Tablet in the Treatment of Postherpetic Neuralgia

U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07758920) titled 'A Clinical Trial to Evaluate the Efficacy and Safety of HL-1186 Tablet in the Treatment of Postherpetic Neuralgia' on Aug. 02.

Brief Summary: This is a multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled, parallel-group trial to evaluate the safety, efficacy and pharmacokinetic (PK) profile of HL-1186 Tablet in patients with postherpetic neuralgia (PHN).

Study Start Date: Aug., 2026

Study Type: INTERVENTIONAL

Condition: Postherpetic Neuralgia ( PHN )

Intervention: DRUG: HL-1186

HL-1186 tablet for oral administration

DRUG: HL-1186 placebo

HL-1186 placebo tablet for oral administration

DRUG: P...